Medicare Enrolled

Dr. William Lumry, M.D.

Optician · Dallas, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
10100 N CENTRAL EXPY, Dallas, TX 75231
2143737374
In practice since 2006 (19 years)
NPI: 1598715914 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lumry from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lumry? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lumry

Dr. William Lumry is an optician in Dallas, TX, with 19 years in practice. Based on federal Medicare data, Dr. Lumry performed 35,130 Medicare services across 1,891 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lumry received a total of $1,340,333 from 42 pharmaceutical and/or device companies across 1617 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lumry is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 2% volume in TX$ $1,340,333 industry payments

Medicare Practice Summary

Medicare Utilization ↗
35,130
Medicare services
Top 2% in TX for optician
1,891
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,849 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Allergy immunotherapy preparation8,946$11$15
Omalizumab injection (Xolair) for asthma/allergy7,230$30$39
Immune globulin infusion (Octagam)7,034$34$43
Allergy skin test3,780$3$4
Professional service for single injection of allergen2,376$7$10
Allergy injection therapy, multiple injections2,232$8$12
Office visit, established patient (20-29 min)1,046$62$89
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour602$16$23
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle458$56$135
Test for allergy using allergenic extract injected into skin358$6$8
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less302$49$74
Office visit, established patient (30-39 min)229$91$127
Flu vaccine administration149$30$31
Flu vaccine, high-dose146$72$73
Test to measure rate of airflow69$29$39
Blood draw (venipuncture)47$8$10
New patient office visit (30-44 min)43$73$113
New patient office visit (45-59 min)29$110$167
Office visit, established patient (10-19 min)16$38$57
Removal of impacted ear wax14$34$47
Telephone medical discussion with physician, 21-30 minutes13$37$61
Telephone medical discussion with physician, 11-20 minutes11$23$40
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
22.6% high complexity
35.0% medium
42.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,340,333
Total received (2018-2024)
Avg $191,476/year across 7 years
Top 0% in TX for optician
42
Companies
1,617
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,167,713 (87.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$156,637 (11.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,982 (1.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$241,895
2023
$219,929
2022
$197,482
2021
$137,516
2020
$68,707
2019
$253,902
2018
$220,901

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Shire North American Group Inc
$268,001
CSL Behring
$249,421
Takeda Pharmaceuticals U.S.A., Inc.
$188,338
BioCryst US Sales Co., LLC
$144,562
AstraZeneca Pharmaceuticals LP
$104,868
GlaxoSmithKline, LLC.
$103,219
Pharming Healthcare, Inc.
$75,174
Regeneron Healthcare Solutions, Inc.
$44,536
BioCryst Pharmaceuticals, Inc.
$37,091
Genentech USA, Inc.
$36,388
Grifols USA, LLC
$16,776
OptiNose US, Inc.
$12,684
Kedrion S.p.A.
$12,014
Consortium of Independent Immunology Clinics, LLC
$10,441
Optinose US, Inc.
$9,383
GENZYME CORPORATION
$5,924
Fresenius Kabi USA, LLC
$5,674
NOVARTIS PHARMACEUTICALS CORPORATION
$5,615
Greer Laboratories, Inc.
$2,000
Amgen Inc.
$1,759
Allergan Inc.
$1,733
Eli Lilly and Company
$800
TerSera Therapeutics LLC
$612
Alnylam Pharmaceuticals Inc.
$568
Vertex Pharmaceuticals Incorporated
$525
PFIZER INC.
$353
ALK-Abello, Inc
$302
BioMarin Pharmaceutical Inc.
$298
Octapharma USA, Inc.
$266
Teva Pharmaceuticals USA, Inc.
$213
Novartis Pharmaceuticals Corporation
$191
ADMA BioManufacturing LLC
$160
Blueprint Medicines Corporation
$132
Bio Products Laboratory USA, Inc.
$102
Boehringer Ingelheim Pharmaceuticals, Inc.
$48
kaleo, Inc.
$31
SANOFI-AVENTIS U.S. LLC
$29
Covis Pharma GmBH
$28
HOSPIRA, INC.
$26
Mylan Specialty L.P.
$16
Circassia Pharmaceuticals Inc
$16
Sunovion Pharmaceuticals Inc.
$13
Top 3 companies account for 52.7% of total payments
Associated products mentioned in payments ›
AIRSUPRA · ALVESCO · ANORO · ANORO ELLIPTA · AREXVY · AUVI-Q · AYVAKIT · AirDuo Digihaler · BREO · BREZTRI · CIBINQO · CINQAIR · CINRYZE · CUTAQUIG · CUVITRU · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · EUCRISA · FASENRA · FIRAZYR · GLASSIA · Gammaplex · Gamunex-C · HYQVIA · Haegarda · Hizentra · Kcentra · NIOX VERO · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ORLADEYO · Odactra · Orladeyo · PANZYGA · PH-Icatibant · PRE-PEN · Prolastin-C Liquid · QVAR · Quzyttir · RUCONEST · SEEBRI · STANDARDIZED · STIOLTO RESPIMAT · SYMBICORT · TAKHZYRO · TEZSPIRE · TIMOTHY · TRELEGY ELLIPTA · XOLAIR · Xembify · Xhance · Xolair
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (87%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for optician in TX.

Equivalent to $3,815 per 100 Medicare services performed
Looking for a optician in Dallas?
Compare opticians in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
504
Per 100K population
19.4
County median income
$74,149
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Lumry is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (speaking/promotional, top 0%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Lumry experienced with allergy immunotherapy preparation?
Based on Medicare claims data, Dr. Lumry performed 8,946 allergy immunotherapy preparation services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lumry receive payments from pharmaceutical companies?
Yes. Dr. Lumry received a total of $1,340,333 from 42 companies across 1,617 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lumry's costs compare to other opticians in Dallas?
Dr. Lumry's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lumry) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →